Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-20 Sale |
2024-09-24 4:01 pm |
Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer |
36,613 | $10.04 | $367,706 | 80,435 (Direct) |
View |
| 2024-09-18 Sale |
2024-09-20 4:00 pm |
Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer |
11,574 | $10.05 | $116,319 | 76,402 (Direct) |
View |
| 2024-09-16 Sale |
2024-09-18 4:01 pm |
Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer |
10,672 | $10.04 | $107,131 | 186,224 (Direct) |
View |
| 2024-09-09 Sale |
2024-09-11 4:00 pm |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer |
20,000 | $9.5 | $190,000 | 101,957 (Direct) |
View |
| 2024-03-11 Sale |
2024-03-12 4:19 pm |
Foghorn Therapeutics Inc. | FHTX | Cavalie Fanny Chief Strategy/Bus Ops Officer |
11,000 | $6.5576 | $72,134 | 75,992 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-09 Gift |
2025-04-10 4:01 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
197,906 | $0 | 511,704 (Indirect) |
View |
| 2025-01-22 Option Award |
2025-01-24 4:16 pm |
N/A 2035-01-21 |
Foghorn Therapeutics Inc. | FHTX | Cardama Alfonso Quintas Chief Medical Officer |
125,000 | $4.37 | 125,000 (Direct) |
View |
| 2025-01-22 Option Award |
2025-01-24 4:15 pm |
N/A 2035-01-21 |
Foghorn Therapeutics Inc. | FHTX | Humer Kristian Chief Financial Officer |
120,000 | $4.37 | 120,000 (Direct) |
View |
| 2025-01-22 Option Award |
2025-01-24 4:13 pm |
N/A 2035-01-21 |
Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer |
115,000 | $4.37 | 115,000 (Direct) |
View |
| 2025-01-22 Option Award |
2025-01-24 4:11 pm |
N/A 2035-01-21 |
Foghorn Therapeutics Inc. | FHTX | Rivkin Anna Chief Business Officer |
50,000 | $4.37 | 50,000 (Direct) |
View |
| 2025-01-22 Option Award |
2025-01-24 4:10 pm |
N/A 2035-01-21 |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
400,000 | $4.37 | 400,000 (Direct) |
View |
| 2025-01-22 Option Award |
2025-01-24 4:09 pm |
N/A 2035-01-21 |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer |
140,000 | $4.37 | 140,000 (Direct) |
View |
| 2025-01-22 Option Award |
2025-01-24 4:06 pm |
N/A 2035-01-21 |
Foghorn Therapeutics Inc. | FHTX | LaCascia Michael Chief Legal Officer |
126,000 | $4.37 | 126,000 (Direct) |
View |
| 2024-09-20 Exercise |
2024-09-24 4:01 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer |
36,613 | $3.72 | 80,435 (Direct) |
View |
| 2024-09-20 Exercise |
2024-09-24 4:01 pm |
N/A 2029-02-12 |
Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer |
36,613 | $0 | 80,435 (Direct) |
View |
| 2024-09-18 Exercise |
2024-09-20 4:00 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer |
11,574 | $3.72 | 76,402 (Direct) |
View |
| 2024-09-18 Exercise |
2024-09-20 4:00 pm |
N/A 2029-02-12 |
Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer |
11,574 | $0 | 76,402 (Direct) |
View |
| 2024-09-16 Exercise |
2024-09-18 4:01 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer |
10,672 | $3.72 | 186,224 (Direct) |
View |
| 2024-09-16 Exercise |
2024-09-18 4:01 pm |
N/A 2029-02-12 |
Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer |
10,672 | $0 | 186,224 (Direct) |
View |
| 2024-09-03 Option Award |
2024-09-04 4:02 pm |
N/A 2034-09-03 |
Foghorn Therapeutics Inc. | FHTX | Rivkin Anna Chief Business Officer |
190,000 | $7.85 | 190,000 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 4:08 pm |
2025-06-26 2034-06-25 |
Foghorn Therapeutics Inc. | FHTX | Biller Scott Director |
16,000 | $5.52 | 16,000 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 4:07 pm |
2025-06-26 2034-06-25 |
Foghorn Therapeutics Inc. | FHTX | Mendelsohn Michael Director |
16,000 | $5.52 | 16,000 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 4:06 pm |
2025-06-26 2034-06-25 |
Foghorn Therapeutics Inc. | FHTX | SMITH IAN F Director |
16,000 | $5.52 | 16,000 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 4:06 pm |
2025-06-26 2034-06-25 |
Foghorn Therapeutics Inc. | FHTX | Lynch Thomas J. Jr. Director |
16,000 | $5.52 | 16,000 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 4:04 pm |
2025-06-26 2034-06-25 |
Foghorn Therapeutics Inc. | FHTX | GILL SIMBA Director |
16,000 | $5.52 | 16,000 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 4:03 pm |
2025-06-26 2034-06-25 |
Foghorn Therapeutics Inc. | FHTX | Cole Douglas G. Director |
16,000 | $5.52 | 16,000 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 4:02 pm |
2025-06-26 2034-06-25 |
Foghorn Therapeutics Inc. | FHTX | PARSHALL B LYNNE Director |
16,000 | $5.52 | 16,000 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 4:00 pm |
2025-06-26 2034-06-25 |
Foghorn Therapeutics Inc. | FHTX | Koppel Adam Director |
16,000 | $5.52 | 16,000 (Direct) |
View |
Ownership |
2024-05-24 5:00 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Flagship Pioneering Fund VII General Partner LLC Flagship Pioneering Fund VII L.P. 10% Owner |
0 | $0 | 1,814,915 (Indirect) |
View |
| 2024-04-16 Option Award |
2024-04-17 4:01 pm |
N/A 2034-04-15 |
Foghorn Therapeutics Inc. | FHTX | Humer Kristian Chief Financial Officer |
275,000 | $6.03 | 275,000 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-25 4:05 pm |
N/A 2034-01-23 |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
300,000 | $3.06 | 300,000 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-25 4:04 pm |
N/A 2034-01-23 |
Foghorn Therapeutics Inc. | FHTX | Cardama Alfonso Quintas Chief Medical Officer |
60,000 | $3.06 | 60,000 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-25 4:03 pm |
N/A 2034-01-23 |
Foghorn Therapeutics Inc. | FHTX | Cavalie Fanny Chief Strategy/Bus Ops Officer |
80,000 | $3.06 | 80,000 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-25 4:03 pm |
N/A 2034-01-23 |
Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer |
90,000 | $3.06 | 90,000 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-25 4:02 pm |
N/A 2034-01-23 |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer |
110,000 | $3.06 | 110,000 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-25 4:01 pm |
N/A 2034-01-23 |
Foghorn Therapeutics Inc. | FHTX | LaCascia Michael Chief Legal Officer |
100,000 | $3.06 | 100,000 (Direct) |
View |
| 2023-12-08 Option Award |
2023-12-12 4:00 pm |
N/A 2033-12-07 |
Foghorn Therapeutics Inc. | FHTX | SMITH IAN F Director |
26,977 | $0 | 26,977 (Direct) |
View |
| 2023-09-11 Option Award |
2023-09-13 4:01 pm |
N/A 2033-09-10 |
Foghorn Therapeutics Inc. | FHTX | Cardama Alfonso Quintas Chief Medical Officer |
272,000 | $7.57 | 272,000 (Direct) |
View |